nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
Adjuvant chemotherapy in resected bile duct cancer: A systematic review and meta-analysis of randomized trials
|
Messina, Carlo |
|
2019 |
143 |
C |
p. 124-129 |
artikel |
2 |
Advances in laparoscopic surgery for cervical cancer
|
Bogani, Giorgio |
|
2019 |
143 |
C |
p. 76-80 |
artikel |
3 |
Editorial Board
|
|
|
2019 |
143 |
C |
p. IFC |
artikel |
4 |
Gut microbiota and cancer: How gut microbiota modulates activity, efficacy and toxicity of antitumoral therapy
|
Gori, Stefania |
|
2019 |
143 |
C |
p. 139-147 |
artikel |
5 |
Hopes and failures in front-line ovarian cancer therapy
|
Tsibulak, Irina |
|
2019 |
143 |
C |
p. 14-19 |
artikel |
6 |
Hormonal therapies in uterine sarcomas, aggressive angiomyxoma, and desmoid-type fibromatosis
|
Pannier, Diane |
|
2019 |
143 |
C |
p. 62-66 |
artikel |
7 |
Immunotherapy and urothelial carcinoma: An overview and future prospectives
|
Pierantoni, Francesco |
|
2019 |
143 |
C |
p. 46-55 |
artikel |
8 |
Integration of palliative, supportive, and nutritional care to alleviate eating-related distress among advanced cancer patients with cachexia and their family members
|
Amano, Koji |
|
2019 |
143 |
C |
p. 117-123 |
artikel |
9 |
Postoperative radiotherapy (PORT) for early oral cavity cancer (pT1-2,N0-1): A review
|
Ivaldi, Eliana |
|
2019 |
143 |
C |
p. 67-75 |
artikel |
10 |
Prophylactic cranial irradiation in extensive disease small cell lung cancer: An endless debate
|
Picardi, Cristina |
|
2019 |
143 |
C |
p. 95-101 |
artikel |
11 |
Systemic therapy for previously treated advanced gastric cancer: A systematic review and network meta-analysis
|
Cheng, Ji |
|
2019 |
143 |
C |
p. 27-45 |
artikel |
12 |
Targeted treatment approaches in refractory germ cell tumors
|
Galvez-Carvajal, Laura |
|
2019 |
143 |
C |
p. 130-138 |
artikel |
13 |
Targeting EGFR pathway in metastatic colorectal cancer- tumour heterogeniety and convergent evolution
|
Khan, Khurum |
|
2019 |
143 |
C |
p. 153-163 |
artikel |
14 |
The clinical significance of soluble PD-1 and PD-L1 in lung cancer
|
Abu Hejleh, Taher |
|
2019 |
143 |
C |
p. 148-152 |
artikel |
15 |
The evolving role of trastuzumab emtansine (T-DM1) in HER2-positive breast cancer with brain metastases
|
Dong, Rongrong |
|
2019 |
143 |
C |
p. 20-26 |
artikel |
16 |
The “pet effect” in cancer patients: Risks and benefits of human-pet interaction
|
Chan, Mei Mei |
|
2019 |
143 |
C |
p. 56-61 |
artikel |
17 |
The TRAIL to cancer therapy: Hindrances and potential solutions
|
Wong, Sonia How Ming |
|
2019 |
143 |
C |
p. 81-94 |
artikel |
18 |
Upfront treatment for newly diagnosed transplant-ineligible multiple myeloma patients: A systematic review and network meta-analysis of 14,533 patients over 29 randomized clinical trials
|
Sekine, Leo |
|
2019 |
143 |
C |
p. 102-116 |
artikel |
19 |
Utility of positron emission tomography/computed tomography (PET/CT) imaging in the evaluation of sarcomas: A systematic review
|
Lim, Hui Jun |
|
2019 |
143 |
C |
p. 1-13 |
artikel |